BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26811492)

  • 1. TSGΔ154-1054 splice variant increases TSG101 oncogenicity by inhibiting its E3-ligase-mediated proteasomal degradation.
    Chua HH; Huang CS; Weng PL; Yeh TH
    Oncotarget; 2016 Feb; 7(7):8240-52. PubMed ID: 26811492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-Specifically Re-Spliced TSG101 mRNA Promotes Invasion and Metastasis of Nasopharyngeal Carcinoma.
    Chua HH; Kameyama T; Mayeda A; Yeh TH
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30759747
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of the GNMT-HectH9-PREX2 tripartite relationship in the pathogenesis of hepatocellular carcinoma.
    Li CH; Yen CH; Chen YF; Lee KJ; Fang CC; Zhang X; Lai CC; Huang SF; Lin HK; Arthur Chen YM
    Int J Cancer; 2017 May; 140(10):2284-2297. PubMed ID: 28205209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
    Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
    Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding.
    Amit I; Yakir L; Katz M; Zwang Y; Marmor MD; Citri A; Shtiegman K; Alroy I; Tuvia S; Reiss Y; Roubini E; Cohen M; Wides R; Bacharach E; Schubert U; Yarden Y
    Genes Dev; 2004 Jul; 18(14):1737-52. PubMed ID: 15256501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic Mutation of AIMP2/p38 Inhibits Its Tumor-Suppressive Interaction with Smurf2.
    Kim DG; Lee JY; Lee JH; Cho HY; Kang BS; Jang SY; Kim MH; Guo M; Han JM; Kim SJ; Kim S
    Cancer Res; 2016 Jun; 76(11):3422-36. PubMed ID: 27197155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of expression and structure of the TSG101 gene in cervical cancer cells.
    Broniarczyk J; Olejnik-Schmidt AK; Luczak MW; Schmidt MT; Dabrowski M; Józefiak A; Kedzia W; Kwasniewska A; Gozdzicka-Józefiak A
    Int J Mol Med; 2010 May; 25(5):777-83. PubMed ID: 20372822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.
    Salah Z; Itzhaki E; Aqeilan RI
    Oncotarget; 2014 Nov; 5(21):10886-900. PubMed ID: 25350971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues.
    Willeke F; Ridder R; Bork P; Klaes R; Mechtersheimer G; Schwarzbach M; Zimmer D; Kloor M; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Mol Carcinog; 1998 Dec; 23(4):195-200. PubMed ID: 9869447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Tsg101 expression by the steadiness box: a role of Tsg101-associated ligase.
    McDonald B; Martin-Serrano J
    Mol Biol Cell; 2008 Feb; 19(2):754-63. PubMed ID: 18077552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation.
    Lu Q; Hope LW; Brasch M; Reinhard C; Cohen SN
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7626-31. PubMed ID: 12802020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
    Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
    Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding.
    Blot V; Perugi F; Gay B; Prévost MC; Briant L; Tangy F; Abriel H; Staub O; Dokhélar MC; Pique C
    J Cell Sci; 2004 May; 117(Pt 11):2357-67. PubMed ID: 15126635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control.
    Li L; Liao J; Ruland J; Mak TW; Cohen SN
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1619-24. PubMed ID: 11172000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TSG101 interacts with apoptosis-antagonizing transcription factor and enhances androgen receptor-mediated transcription by promoting its monoubiquitination.
    Burgdorf S; Leister P; Scheidtmann KH
    J Biol Chem; 2004 Apr; 279(17):17524-34. PubMed ID: 14761944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSG101, identified by screening a cancer cDNA library and soft agar assay, promotes cell proliferation in human lung cancer.
    Liu F; Yu Y; Jin Y; Fu S
    Mol Biol Rep; 2010 Jul; 37(6):2829-38. PubMed ID: 19787439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spongiform neurodegeneration-associated E3 ligase Mahogunin ubiquitylates TSG101 and regulates endosomal trafficking.
    Kim BY; Olzmann JA; Barsh GS; Chin LS; Li L
    Mol Biol Cell; 2007 Apr; 18(4):1129-42. PubMed ID: 17229889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal regulation of TSG101 in mice with spongiform neurodegeneration.
    Jiao J; Sun K; Walker WP; Bagher P; Cota CD; Gunn TM
    Biochim Biophys Acta; 2009 Oct; 1792(10):1027-35. PubMed ID: 19703557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
    Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MGRN1-dependent pigment-type switching requires its ubiquitination activity but not its interaction with TSG101 or NEDD4.
    Gunn TM; Silvius D; Bagher P; Sun K; Walker KK
    Pigment Cell Melanoma Res; 2013 Mar; 26(2):263-8. PubMed ID: 23253940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.